Intestinal Research

Search: Intest Res Search

CLOSE

Intestinal Research

‘Intestinal Research’ (Intest Res) is the joint official publication of the Asian Organization for Crohn's and Colitis (AOCC), Chinese Society of IBD (CSIBD), Japanese Society for IBD (JSIBD), Korean Association for the Study of Intestinal Diseases (KASID), Taiwan Society of IBD (TSIBD) and Colitis Crohn's Foundation (India) (CCF, india).

The aim of the Journal is to provide broad and in-depth analysis of intestinal diseases, especially inflammatory bowel disease, which shows increasing tendency and significance.As a Journal specialized in clinical and translational research in gastroenterology, it encompasses multiple aspects of diseases originated from the small and large intestines.

Review

July 26, 2022

Endoscopic diagnosis and treatment of early colorectal cancer

Seung Wook Hong, Jeong-Sik Byeon

Intest Res. 2022;20(3):281-290.

Early colorectal cancer refers to cancer in the colorectum that is confined to the mucosa or submucosa and does not invade the muscularis propria, irrespective of lymph node or distant...

Review

January 7, 2022

Landscape of inflammatory bowel disease in Singapore

Daren Low, Nidhi Swarup, Toshiyuki Okada, et al.

Intest Res. 2022;20(3):291-296.

Inflammatory bowel disease (IBD), primarily Crohn’s disease and ulcerative colitis, had been widely recognized to affect the Western population. However, the notable rise in prevalence of IBD in Asia, including...

Original Article

August 4, 2021

Factors associated with anti-tumor necrosis factor effectiveness to prevent postoperative recurrence in Crohn’s disease

Anthony Buisson, Lisa Cannon, Konstantin Umanskiy, et al.

Intest Res. 2022;20(3):303-312.

Background/Aims: We assessed the effectiveness of anti-TNF agents and its associated factors to prevent endoscopic and clinical postoperative recurrence (POR) in Crohn’s disease (CD). Methods: From a prospectively-maintained database, we...

Original Article

March 12, 2021

Risk factors for non-reaching of ileal pouch to the anus in laparoscopic restorative proctocolectomy with handsewn anastomosis for ulcerative colitis

Shigenobu Emoto, Keisuke Hata, Hiroaki Nozawa, et al.

Intest Res. 2022;20(3):313-320.

Background/Aims: Restorative proctocolectomy (RPC) with ileal pouch-anal anastomosis and handsewn anastomosis for ulcerative colitis requires pulling down of the ileal pouch into the pelvis, which can be technically challenging. We...

Original Article

July 20, 2021

Evaluation of nutritional status using bioelectrical impedance analysis in patients with inflammatory bowel disease

Seung Hyuk Kim, You Sun Kim, Si Hyeong Lee, et al.

Intest Res. 2022;20(3):321-328.

Background/Aims: Nutritional status influences quality of life among patients with inflammatory bowel disease (IBD), although there is no clear method to evaluate nutritional status in this setting. Therefore, this study...

Original Article

August 4, 2021

Real-world data for golimumab treatment in patients with ulcerative colitis in Japan: interim analysis in post-marketing surveillance

Shiro Nakamura, Teita Asano, Hiroaki Tsuchiya, et al.

Intest Res. 2022;20(3):329-341.

Background/Aims: Golimumab (GLM) is an anti-tumor necrosis factor-α drug approved for treating moderate-to-severe active ulcerative colitis (UC). A 52-week post-marketing surveillance (PMS) was initiated to evaluate its safety and effectiveness...

Original Article

May 21, 2021

A nationwide analysis on the influence of obesity in inflammatory bowel disease hospitalizations

Dushyant Singh Dahiya, Asim Kichloo, Farah Wani, et al.

Intest Res. 2022;20(3):342-349.

Background/Aims: Proinflammatory cytokines released from adipocytes can influence the development, progression, and treatment of inflammatory bowel disease (IBD), and may be associated with worse clinical outcomes. Methods: For 2016–2018, we...

Original Article

July 23, 2021

Clinical outcomes and predictors of response for adalimumab in patients with moderately to severely active ulcerative colitis: a KASID prospective multicenter cohort study

Seung Yong Shin, Soo Jung Park, Young Kim, et al.

Intest Res. 2022;20(3):350-360.

Background/Aims: This study assessed the efficacy and safety of adalimumab (ADA) and explored predictors of response in Korean patients with ulcerative colitis (UC). Methods: A prospective, observational, multicenter study was conducted...

Original Article

March 15, 2022

Intestinal ultrasonography and fecal calprotectin for monitoring inflammation of ileal Crohn’s disease: two complementary tests

José María Paredes, Tomás Ripollés, Ángela Algarra, et al.

Intest Res. 2022;20(3):361-369.

Background/Aims: Tight control of inflammation and adjustment of treatment if activity persists is the current strategy for the management of Crohn’s disease (CD). The usefulness of fecal calprotectin (FC) in...

Original Article

May 14, 2021

Relationship between the gut microbiota and bile acid composition in the ileal mucosa of Crohn’s disease

Shigeki Bamba, Osamu Inatomi, Atsushi Nishida, et al.

Intest Res. 2022;20(3):370-380.

Background/Aims: Crosstalk between the gut microbiota and bile acid plays an important role in the pathogenesis of gastrointestinal disorders. We investigated the relationship between microbial structure and bile acid metabolism...

Current Issue: Volume 20(3); Jul 2022

This archive contains links to the full-text of all issues of Intest Res.

All issues

Vol. 20
2022

v.20(1)
Jan 2022

v.20(2)
Apr 2022

v.20(3)
Jul 2022

Vol. 19
2021

v.19(1)
Jan 2021

v.19(2)
Apr 2021

v.19(3)
Jul 2021

v.19(4)
Oct 2021

Vol. 18
2020

v.18(1)
Jan 2020

v.18(2)
Apr 2020

v.18(3)
Jul 2020

v.18(4)
Oct 2020

Vol. 17
2019

v.17(1)
Jan 2019

v.17(2)
Apr 2019

v.17(3)
Jul 2019

v.17(4)
Oct 2019

Vol. 16
2018

v.16(1)
Jan 2018

v.16(2)
Apr 2018

v.16(3)
Jul 2018

v.16(4)
Oct 2018

Vol. 15
2017

v.15(1)
Jan 2017

v.15(2)
Apr 2017

v.15(3)
Jul 2017

v.15(4)
Oct 2017

Vol. 14
2016

v.14(1)
Jan 2016

v.14(2)
Apr 2016

v.14(3)
Jul 2016

v.14(4)
Oct 2016

Vol. 13
2015

v.13(1)
Jan 2015

v.13(2)
Apr 2015

v.13(3)
Jul 2015

v.13(4)
Oct 2015

Vol. 12
2014

v.12(1)
Jan 2014

v.12(2)
Apr 2014

v.12(3)
Jul 2014

v.12(4)
Oct 2014

Vol. 11
2013

v.11(1)
Jan 2013

v.11(2)
Apr 2013

v.11(3)
Jul 2013

v.11(4)
Oct 2013

Vol. 10
2012

v.10(1)
Feb 2012

v.10(2)
Apr 2012

v.10(3)
Jul 2012

v.10(4)
Oct 2012

Vol. 9
2011

v.9(1)
Apr 2011

v.9(2)
Aug 2011

v.9(3)
Dec 2011

Vol. 8
2010

v.8(1)
Jun 2010

v.8(2)
Dec 2010

Vol. 7
2009

v.7(1)
Jun 2009

v.7(2)
Dec 2009

Vol. 6
2008

v.6(1)
Jun 2008

v.6(2)
Dec 2008

Vol. 5
2007

v.5(1)
Jun 2007

v.5(2)
Dec 2007

Vol. 4
2006

v.4(1)
Jun 2006

v.4(2)
Dec 2006

Vol. 3
2005

v.3(1)
Jun 2005

v.3(2)
Dec 2005

Vol. 2
2004

v.2(1)
Apr 2004

v.2(2)
Dec 2004

Vol. 1
2003

v.1(1)
May 2003

v.1(2)
Nov 2003

ARTICLE & TOPICS

Article Category

Browse all articles >

Browse all articles >

BROWSE ARTICLES

EDITORIAL POLICY

AUTHOR INFORMATION

Editorial Office: Room 310, Lotte Gold Rose II, 31 Seolleung-ro 86-gil, Gangnam-gu, Seoul 06193, Korea
Tel: +82-2-957-6145 Fax: +82-2-957-6146 E-mail: thekasid@irjournal.org

Copyright © 2022 by Korean Association for the Study of Intestinal Diseases.

prev

next

prev

next